Inmedix Inc

Inmedix next-gen heart rate variability (HRV) measures stress biology with FDA precision and enables new solutions to block how stress drives and even causes disease. This most advanced and proprietary ...

Inmedix next-gen heart rate variability (HRV) measures stress biology with FDA precision and enables new solutions to block how stress drives and even causes disease.

This most advanced and proprietary for of HRV stress assessment comes from elite sports and US Special Forces training, and is being brought through the FDA and into clinics as a reimbursed, point-of-service, clinical diagnostic. Next-gen HRV is the most precise measure of stress biology, and Inmedix will launch in rheumatology based on our 9 clinical studies to date.

The science is called immuno-autonomics and is applied on a cloud platform.

It improves outcomes for patients, provides a new revenue stream for clinicians, reduces cost of care for payers (projected by UW to be $34B over 10 years), and for pharma, it provides centralized, proprietary data for drug label expansion and discovery to curb the adverse effects of stress on health.

---

Write the first review

Resource tags